Brand Name
Avanafil
View Brand InformationFDA approval date: June 14, 2024
Classification: Phosphodiesterase 5 Inhibitor
Form: Tablet
What is Avanafil?
Avanafil tablets are a phosphodiesterase 5 inhibitor indicated for the treatment of erectile dysfunction in adult males. Avanafil tablet is a phosphodiesterase 5 inhibitor indicated for the treatment of erectile dysfunction
Approved To Treat
Top Global Experts
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment